Radiology’s Fight Against Prior Authorization Delays
ACR is leading national efforts to make prior authorization more efficient and clinically appropriate while reducing the administrative burden and supporting national legislation.
Read moreMain Content
ACR Supports Legislation to Reform Radiation Oncology Payment
May 16, 2024
The Radiation Oncology Case Rate (ROCR) Value-Based Program Act of 2024 (S. 4330 /H.R.8404) was introduced this week by U.S. Sen. Thomas Tillis (R-NC) and Reps. Brian Fitzpatrick (R-PA), Jimmy Panetta (D-CA), John Joyce, MD (R-PA) and Paul Tonko (D-NY). The legislation would increase patient access to care, improve the quality of cancer treatments, reduce disparities for rural and underserved patients, and lower patient costs while achieving significant savings for Medicare.
Radiation oncology experienced severe Medicare reimbursement cuts, exceeding 20% over the last 10 years. At the same time, radiation oncology practices continue to face rising costs as cutting-edge technology and skilled treatment teams get more expensive; this is not sustainable. The American Society for Radiation Oncology (ASTRO) and other organizations from the oncology community, including ACR, support S. 4330/H.R. 8404 to reform radiation oncology payment.
Radiation oncology is a highly cost-effective cancer treatment, yet Medicare spends less on radiation oncology treatments than it does on just three cancer drugs. While the Centers for Medicare and Medicaid Services (CMS) recognized and attempted to address these unique challenges with a proposed radiation oncology model (RO model), the model has failed to achieve value-based care goals due to excessive payment cuts and administrative burdens. CMS indefinitely delayed implementation of the RO model in August 2022. Learning from the RO model (S. 4330 /H.R. 8404) will enable advances for people with cancer.
The ROCR payment program would: change radiation oncology payment from per fraction to per patient; reverse decade-long declines in Medicare payments; and usher in a new era of stable payments, higher quality care, and reduced disparities.
For additional information, contact Christina Berry, Team Lead for Economic Policy.
Radiation oncology experienced severe Medicare reimbursement cuts, exceeding 20% over the last 10 years. At the same time, radiation oncology practices continue to face rising costs as cutting-edge technology and skilled treatment teams get more expensive; this is not sustainable. The American Society for Radiation Oncology (ASTRO) and other organizations from the oncology community, including ACR, support S. 4330/H.R. 8404 to reform radiation oncology payment.
Radiation oncology is a highly cost-effective cancer treatment, yet Medicare spends less on radiation oncology treatments than it does on just three cancer drugs. While the Centers for Medicare and Medicaid Services (CMS) recognized and attempted to address these unique challenges with a proposed radiation oncology model (RO model), the model has failed to achieve value-based care goals due to excessive payment cuts and administrative burdens. CMS indefinitely delayed implementation of the RO model in August 2022. Learning from the RO model (S. 4330 /H.R. 8404) will enable advances for people with cancer.
The ROCR payment program would: change radiation oncology payment from per fraction to per patient; reverse decade-long declines in Medicare payments; and usher in a new era of stable payments, higher quality care, and reduced disparities.
For additional information, contact Christina Berry, Team Lead for Economic Policy.
Related ACR News
ACR Supports Medicaid Coverage of Lung Cancer Screening
ACR-backed bill would mandate Medicaid lung cancer screening, expand cessation coverage, ban prior auth—aiming to save lives and reduce disparities.
Read morePatient-Centered Imaging Care Led by Radiologists
ACR helps its state chapters fight scope of practice expansion, such as helping to oppose bills in state legislatures that would allow non-physicians to practice independently.
Read more